Levothyroxine |
Levothroid; Levoxine; Levoxyl; Synthroid; Unithroid |
Levothyroxine Systematic (IUPAC) name 3,5,3',5'-tetraiodo-L-thyronine Identifiers CAS number 51-48-9 ATC code H03AA01 PubChem 853 DrugBank APRD00235 Chemical data Formula C15H10I4NNaO4 * H2O Mol. weight 798.86 (anhydrous) Pharmacokinetic data Bioavailability ~100% Metabolism Mainly in liver, kidneys, brains and muscles Half life ca. 7 days (in hyperthyroidism 3-4 days, in hypothyroidism 9-10 days) Excretion Through faeces and urine Therapeutic considera ...
Wikipedia - [full article]
Levothyroxine Clinical Trials
- Levothyroxine Treatment in Thyroid Benign Nodular Goiter
ClinicalTrials.gov Identifier: NCT00552253 - Recruiting
Thyroid Nodule
- Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
ClinicalTrials.gov Identifier: NCT00488644 - Recruiting
Hypothyroidism; Brain Tumor
- Generic vs. Name-Brand Levothyroxine
ClinicalTrials.gov Identifier: NCT00403390 - Recruiting
Congenital Hypothyroidism; Hypothyroidism
- Block-Replacement Therapy During Radioiodine Therapy
ClinicalTrials.gov Identifier: NCT00150124 - Recruiting
toxic nodular goitre; Graves'' disease
- The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients With Subclinical Hypothyroidism
ClinicalTrials.gov Identifier: NCT00498238 - Completed
Subclinical Hypothyroidism

Not Signed In -


